Novartis, Pfizer seek U.S. approval of meningitis vaccines

June 17 (Reuters) - Pfizer Inc and rival Swiss drugmaker Novartis AG on Tuesday said they had asked U.S. regulators to approve their vaccines to prevent meningitis infections in people aged 10 to 25.